![Dennis Mulroy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Mulroy
Financieel Directeur/CFO bij
ARCTURUS THERAPEUTICS HOLDINGS INC.
Vermogen: 692 332 $ op 30-09-2026
Profiel
Mr. Dennis M.
Mulroy, CPA, is a Chief Financial Officer at Arcturus Therapeutics Holdings, Inc. Mr. Mulroy was previously employed as a Chief Financial Officer by AnaptysBio, Inc., a CEO, Chief Financial & Accounting Officer by La Jolla Pharmaceutical Co., a Chief Financial Officer, Treasurer & Director by Tissue Repair Co., a Chief Financial Officer by Post-Hypothermia Corp., a Chief Financial Officer by Aries Ventures, Inc., a Chief Financial Officer by Gene Biotherapeutics, Inc., a Chief Financial Officer by Molecular Imaging Corp., a Chief Financial Officer by SeraCare Life Sciences, Inc., and a Chief Financial Officer by Bioceutix, Inc. He received his undergraduate degree from the University of San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ANAPTYSBIO, INC. 0,05% | 01-06-2026 | 13.775 ( 0,05% ) | 692 332 $ | 30-09-2026 |
Actieve functies van Dennis Mulroy
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Financieel Directeur/CFO | 01-05-2026 |
Eerdere bekende functies van Dennis Mulroy
| Bedrijven | Functie | Einde |
|---|---|---|
| ANAPTYSBIO, INC. | Financieel Directeur/CFO | 20-04-2026 |
| LA JOLLA PHARMACEUTICAL COMPANY | Algemeen Directeur | 31-05-2020 |
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Financieel Directeur/CFO | 03-04-2015 |
Tissue Repair Co.
 Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Financieel Directeur/CFO | 02-01-2013 |
Aries Ventures, Inc.
 Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Financieel Directeur/CFO | 23-01-2006 |
Opleiding van Dennis Mulroy
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
60
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Aries Ventures, Inc.
Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Finance |
Molecular Imaging Corp.
 Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Provides molecular imaging services | Health Services |
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Health Technology |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
Bioceutix, Inc. | |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
